|
|
|
|
 |
LA JOLLA--- Transdel Pharmaceuticals Closes $4 Million Financing |
| 5/15/2008 @ 8:57 AM
print this article -
email to a friend -
join our eNewsletter
|
 |
Transdel Pharmaceuticals, Inc. (BULLETIN BOARD: TDLP) , a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically administered medications, today announced the closing of a $4,000,000 private placement of its common stock and warrants.
The Company issued 1,818,180 shares of common stock at a price of $2.20 per share through a private placement to accredited investors. In addition, the investors received warrants to purchase 227,272 shares of common stock for a period of five years at a cash and cashless exercise price of $4.40 and $5.50 per share, respectively.
Proceeds from the financing will be primarily used to fund the Company's Phase 3 clinical program of Ketotransdel , the Company's lead topical pain drug. Ketotransdel is a novel, topical cream-based formulation containing the non-steroidal anti-inflammatory drug ("NSAID") ketoprofen. The registration trial will be a randomized, double-blind, placebo controlled Phase 3 trial to study the efficacy and safety of Ketotransdel in acute soft tissue injuries.
Dr. Juliet Singh, President and Chief Executive Officer of Transdel Pharmaceuticals, stated, "We are very pleased to have closed this round of financing, as we plan to initiate our Phase 3 clinical study in the second quarter of this year. We are quite confident in our Phase 3 clinical study design, especially since our protocol was carefully reviewed by external experts and the U.S. Food and Drug Administration ("FDA"). We believe that Ketotransdel may address a significant unmet medical need for effective topical pain treatment without the gastrointestinal, cardiovascular and other safety concerns associated with oral pain medications."
The Company is exploring potential partnerships with U.S. and foreign based companies that have sales and marketing infrastructures to support Ketotransdel in the event that the product is approved and commercialized. The Company is also looking to out-license its Transdel drug delivery technology for the development and commercialization of additional innovative drug products. There can be no assurance that any of these activities will lead to definitive agreements.
The market for NSAIDs and Cox-2 inhibitors exceeds $6 billion per year and more than 30 million people worldwide use NSAIDs daily. Due to the recognition of cardiovascular, gastrointestinal and other risks associated with orally administered NSAIDs, and the decline in the use of Cox-2 inhibitors because of safety concerns, the Company believes that there is a significant demand for topical pain management products such as Ketotransdel . If approved by the FDA, Ketotransdel has the potential to be the first topical NSAID cream product in the United States for acute pain management.
About Transdel Pharmaceuticals, Inc.
Transdel Pharmaceuticals, Inc. (BULLETIN BOARD: TDLP) is a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically delivered medications. The Company's innovative patented proprietary Transdel cream formulation technology is designed to facilitate the effective penetration of drugs through the tough skin barrier to reach the target underlying tissues. In the case of Ketotransdel , the Transdel cream allows the active ingredient ketoprofen to reach the target soft tissue and exert its well-known anti-inflammatory and analgesic effects. The Company is also investigating other drug candidates and treatments for transdermal delivery using the patented Transdel platform technology for products in pain management and other therapeutic areas. |
| FreshMoney - California Mergers/Acquisitions/Funding |
|
|
| |
| Tuesday, July 8, 2008 |
 |
|
SAN DIEGO--- Lilly to Acquire SGX Pharmaceuticals; Deal Expands Lilly's Structure-Based Drug Discovery Capabilities Posted 4:35 PM PST
MENLO PARK--- Longitude Capital Closes $325 Million Life Sciences Fund Posted 8:11 AM PST
LOS GATOS--- Iwatt, Inc. Raises $12.4 Million in Series E Financing Posted 8:00 AM PST
PALO ALTO--- Vmware Announces Change in Executive Leadership Posted 7:59 AM PST
SAN DIEGO--- The Active Network Establishes Leadership Position in Swimming and Track & Field Markets with Acquisition of HY-TEK Sports Software Businesses Posted 7:46 AM PST
|
| |
| Monday, July 7, 2008 |
|
|
LOS ANGELES--- Signalife and Heart One Global Research Agree to Merge Posted 6:43 AM PST
|
| |
| Thursday, July 3, 2008 |
|
|
PALO ALTO--- Wellington Partners Invests Over $17 Million in GameDuell Posted 10:03 AM PST
SAN FRANCISCO--- GoFish Corporation Secures Remaining $2 Million Portion of Private Placement Totaling $3.5 Million Posted 10:00 AM PST
|
| |
| Wednesday, July 2, 2008 |
|
|
REDWOOD CITY--- Pearl Therapeutics Closes $18 Million Financing Round Posted 6:49 AM PST
SAN CARLOS--- Natus Medical Acquires Schwarzer GmbH Neurology Division Posted 6:41 AM PST
|
| |
| Tuesday, July 1, 2008 |
|
|
WASHINGTON--- Icx Wins $14 Million Cerberus Mobile Surveillance Towers Contract for U.S. Army Posted 4:39 PM PST
SAN JOSE--- Agiliance Secures $10 Million in Series B Funding Posted 8:24 AM PST
CARLSBAD--- Abbott Invests Additional $20M in Isis' Subsidiary Ibis Biosciences Posted 7:45 AM PST
SAN DIEGO--- Dataskill Announces Agreement to Acquire Silicon Space Posted 7:12 AM PST
|
| |
| Monday, June 30, 2008 |
|
|
SAN DIEGO--- TAG Acquires Contractor Software Corporation Posted 3:21 PM PST
SAN FRANCISCO--- CBS Corporation Completes Acquisition of CNET Networks; Merges Operations Into New, Expanded CBS Interactive Business Unit Posted 3:19 PM PST
SAN DIEGO--- Overland Acquires Adaptec's Snap Server NAS Business to Further Extend the Reach of Its End-to-End Data Protection Offerings Posted 6:45 AM PST
NOVATO--- Raptor Pharmaceuticals Closes $10 Million Private Placement Posted 6:43 AM PST
|
| |
| Saturday, June 28, 2008 |
|
|
MILPITAS--- Credence and LTX Sign Merger Agreement Posted 10:06 AM PST
|
| |
| Friday, June 27, 2008 |
|
|
SAN FRANCISCO--- New Media Animation Pioneer aniBoom Secures Additional $10 Million in Funding Posted 6:30 AM PST
|
| |
| Thursday, June 26, 2008 |
|
|
SAN JOSE--- Orbotech Reaches Agreement to Acquire Photon Dynamics Posted 9:13 AM PST
CUPERTINO--- Miyowa Raises $8 Million in Additional Venture Capital Financing Posted 9:12 AM PST
|
| |
| Wednesday, June 25, 2008 |
|
|
LOS ANGELES--- $8.4 Million in Series B Funding to Opinion Maker SodaHead Posted 8:44 AM PST
|
|
|
|
|
|
FreshNews.com Jobs Change DAILY
We Have 5,000 + Job Listings! Open Your FREE Account
Employers or Job Searchers Get Started Now! Click Here
|
